Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis for Early VAP in Neurological Patients
NCT01118403Phase 4Withdrawn
- Sponsor
- Hospital Pablo Tobón Uribe
- Start
- Mar 2011
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sultamicillin in ventilator-associated pneumonia (VAP), sponsored by Hospital Pablo Tobón Uribe. Planned start Mar 2011; status: withdrawn.
02
Drugs
sultamicillin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT01118403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118403.